Um alle Funktionen dieser Seite zu nutzen, aktivieren Sie bitte die Cookies in Ihrem Browser.
Meine Merkliste
my.bionity.com
my.bionity.com
Mit einem my.bionity.com-Account haben Sie immer alles im Überblick - und können sich Ihre eigene Website und Ihren individuellen Newsletter konfigurieren.
- Meine Merkliste
- Meine gespeicherte Suche
- Meine gespeicherten Themen
- Meine Newsletter
1.838 Aktuelle Fachpublikationen von Future Medicine
rss
Personalized healthcare in the era of value-based healthcare
07.05.2013 | Kathryn A Teng; David L Longworth, Personalized Medicine, 2013
Medical care in the USA is plagued by high costs, poor quality and fragmented care delivery. In response, new methods of integrated healthcare delivery are needed, including the patient-centered medical home. At the same time, we need to revitalize our approach to the practice of medicine, ...
The current and future role of sequence-based analysis in prostate cancer treatment
07.05.2013 | Won Kim; Phillip G Febbo, Personalized Medicine, 2013
Prostate cancer is the most commonly diagnosed, nondermatologic malignancy in US men. Localized disease can be managed through active surveillance or curative, locally directed therapies, but 30% of men treated with surgery or radiation will need additional (often systemic) treatment for ...
Research Highlights: Highlights from the latest articles in personalized medicine
07.05.2013 | Joanne Ngeow; Charis Eng, Personalized Medicine, 2013
Personalized Medicine , May 2013, Vol. 10, No. 3, Pages 231-233.
Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers
07.05.2013 | Michael D Graf; Denise F Needham; Nicole Teed; Trisha Brown, Personalized Medicine, 2013
Aim: Health plan coverage policies can influence utilization of genetic tests. Our goal was to characterize the current state of test-related policies from US private payers. Methods: We searched the public websites of 206 insurers for coverage policies. We documented the number of policies, ...
The genomic medicine model: an integrated approach to implementation of family health history in primary care
07.05.2013 | Lori A Orlando; Vincent C Henrich; Elizabeth R Hauser; Charles Wilson; Geoffrey S Ginsburg, Personalized Medicine, 2013
As an essential tool for risk stratification, family health history (FHH) is a central component of personalized medicine; yet, despite its widespread acceptance among professional societies and its established place in the medical interview, its widespread adoption is hindered by three major ...
Technological evolution of diagnostic testing in oncology
07.05.2013 | Julius Alexander Steffen; Christian Lenz, Personalized Medicine, 2013
Diagnostic testing has been improving the quality of cancer care. The dynamics of this field can be grasped through the application of innovation lifecycle models. Single testing, parallel testing and whole-genome sequencing are major technological evolutions. Given the increasing ...
A national study of breast and colorectal cancer patients’ decision-making for novel personalized medicine genomic diagnostics
07.05.2013 | Amalia M Issa; Waqas Tufail; Nelson Atehortua; John McKeever, Personalized Medicine, 2013
Aim: Molecular diagnostics are increasingly being used to help guide decision-making for personalized medical treatment of breast and colorectal cancer patients. The main aim of this study was to better understand and determine breast and colorectal cancer patients’ decision-making strategies ...
Acknowledgements
07.05.2013 | Personalized Medicine, 2013
Personalized Medicine , May 2013, Vol. 10, No. 3, Pages 319-319.
Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses
07.05.2013 | Darren R Tyson; Vito Quaranta, Personalized Medicine, 2013
Personalized Medicine , May 2013, Vol. 10, No. 3, Pages 221-225.
Sie erhalten passend zu Ihrer Suche die neusten Suchergebnisse per E-Mail. Dieser Service ist für Sie kostenlos und kann jederzeit abbestellt werden.
Netmeeting
